Magnus Medical is a privately held medical device company developing breakthrough technology for rapid, individualized, non-invasive treatment of major depression. It is our mission to restore and sustain mental health. Depression is caused by identifiable changes in brain networks. With individualized, accelerated treatment, we aim to offer people with treatment-resistant depression the ability to manage their symptoms acutely and stay well throughout their lives.
The U.S. Food & Drug (FDA) has awarded Breakthrough Device Designation to our investigational neuromodulation technology to rapidly treat major depressive disorder (MDD) in adults who have not responded to existing treatments.
Member count: 11-50
Total raised: $25M
Investors 1
| Date | Name | Website |
| 15.12.2020 | JAZZ Ventu... | jazzvp.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 29.10.2021 | Series A | $25M | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 02.11.2021 | Magnus Med... | (Graphic: Magnus Medical) Mag... | USA | - | finsmes.co... |
| 01.11.2021 | Magnus Med... | Magnus Medical has raised $25 ... | - | - | pitchbook.... |
| 29.10.2021 | Magnus Med... | Magnus Medical, Inc., a Burlin... | USA | - | finsmes.co... |
| 29.10.2021 | The lines ... | This is the web version of Ter... | - | - | fortune.co... |
| 29.10.2021 | Magnus Med... | Magnus Medical, Inc., a medica... | - | - | marketscre... |